(Q55462991)

12 July 2018

title

Immunohistochemical analysis of 1844 human epithelial and haematopoietic tumours and sarcomas for IDH1R132H mutation. (English)

1 reference

12 July 2018

1 reference

1

1 reference

12 July 2018

Andreas von Deimling

10

Andreas von Deimling

1 reference

12 July 2018

2

David Capper

1 reference

12 July 2018

9

Werner Paulus

1 reference

12 July 2018

Gunhild Mechtersheimer

7

Gunhild Mechtersheimer

1 reference

12 July 2018

Iver Petersen

8

Iver Petersen

1 reference

12 July 2018

Esther Herpel

5

Esther Herpel

1 reference

12 July 2018

author name string

Jochen Meyer

3

1 reference

12 July 2018

Christian Hartmann

4

1 reference

12 July 2018

Mindaugas Andrulis

6

1 reference

12 July 2018

publication date

1 June 2011

1 reference

12 July 2018

published in

Histopathology

1 reference

12 July 2018

volume

58

1 reference

12 July 2018

issue

7

1 reference

12 July 2018

page(s)

1167-1172

1 reference

12 July 2018

Analysis of the IDH1 codon 132 mutation in brain tumors

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03823.X

Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03823.X

Recurring mutations found by sequencing an acute myeloid leukemia genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03823.X

Distinct clinical and biologic characteristics in adult acute myeloid leukemia bearing the isocitrate dehydrogenase 1 mutation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03823.X

The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03823.X

Cancer-associated metabolite 2-hydroxyglutarate accumulates in acute myelogenous leukemia with isocitrate dehydrogenase 1 and 2 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03823.X

IDH1 mutations at residue p.R132 (IDH1(R132)) occur frequently in high-grade gliomas but not in other solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03823.X

Mutational analysis of IDH1 codon 132 in glioblastomas and other common cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03823.X

An integrated genomic analysis of human glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03823.X

NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03823.X

IDH1 and IDH2 mutations in gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03823.X

IDH1 mutations are present in the majority of common adult gliomas but rare in primary glioblastomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03823.X

Cancer-associated IDH1 mutations produce 2-hydroxyglutarate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03823.X

A gene encoding a putative FAD-dependent L-2-hydroxyglutarate dehydrogenase is mutated in L-2-hydroxyglutaric aciduria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03823.X

L-2-hydroxyglutaric aciduria and brain malignant tumors: a predisposing condition?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03823.X

L-2-Hydroxyglutaric aciduria: identification of a mutant gene C14orf160, localized on chromosome 14q22.1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03823.X

Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03823.X

Monoclonal antibody specific for IDH1 R132H mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03823.X

Characterization of R132H mutation-specific IDH1 antibody binding in brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03823.X

Application of mutant IDH1 antibody to differentiate diffuse glioma from nonneoplastic central nervous system lesions and therapy-induced changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03823.X

The genomic landscapes of human breast and colorectal cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03823.X

The consensus coding sequences of human breast and colorectal cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03823.X

Identification and functional characterization of isocitrate dehydrogenase 1 (IDH1) mutations in thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03823.X

Detection of isocitrate dehydrogenase 1 mutation R132H in myelodysplastic syndrome by mutation-specific antibody and direct sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03823.X

10.1111/J.1365-2559.2011.03823.X

21 January 2018

Identifiers

DOI

1 reference

12 July 2018

1 reference

12 July 2018